Breast MRI as a radiomic biomarker of immune enrichment in HER2+ breast cancer.

Laura Kennedy,Grace Durenberger,Sasha E. Stanton,Shaveta Vinayak,Suzanne M. Dintzis,Savannah C. Partridge,Vijayakrishna K. Gadi

Breast MRI as a radiomic biomarker of immune enrichment in HER2+ breast cancer.

2019

Laura Kennedy
Grace Durenberger
Sasha E. Stanton
Shaveta Vinayak
Suzanne M. Dintzis
Savannah C. Partridge
Vijayakrishna K. Gadi

e14281Background: Trastuzumab is an important drug in the treatment (tx) of HER2+ breast cancer, but not all tumors are responsive. Immune-enriched tumors have a better response to tx, and a biomar...

Keywords:

Breast MRI
Breast cancer
Immune system
Oncology
Biomarker (medicine)
Pathology
Medicine
Internal medicine
Drug
Trastuzumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations